IHH Healthcare Deepens Commitment to Reduce Cancer Burden in Malaysia - IHH Healthcare
  • Join our community
  • IHH@LinkedIn
  • IHH@Youtube
  • IHH@Facebook
IHH Healthcare Deepens Commitment to Reduce Cancer Burden in Malaysia
08 Jul 2025

Learn how our third memorandum of understanding with Ministry of Health Malaysia is expanding access to life-saving, advanced cancer care at 8 of our hospitals.

 

 

IHH Healthcare Malaysia has inked its third Memorandum of Understanding (MOU) with the Ministry of Health Malaysia, reaffirming our commitment to making advanced cancer treatment accessible to more Malaysians.

The collaboration will fully sponsor radiotherapy and radiosurgery for an additional 500 patients referred from government hospitals. Since its launch in 2022, this public-private initiative has enabled 1,000 cancer patients to receive high-quality treatment at no cost through our Malaysia hospital network.

"This collaboration is a concrete step toward closing the access gap for underserved and lower-income groups. It also reflects Malaysia's broader commitment to Universal Health Coverage, where cancer care is not treated as a privilege but as a right. We should never allow a patient's health outcome to be dictated by where they live or how much they earn,” said Health Minister, YB Datuk Seri Dr Haji Dzulkefly Ahmad during the signing ceremony held at the Malaysia Ministry of Health Multipurpose Hall on 7 July 2025.

This latest agreement will also include Island Hospital Penang, bringing the total number of participating IHH Healthcare Malaysia hospitals to eight. The other seven participating hospitals are Gleneagles Hospital Johor, Gleneagles Hospital Kuala Lumpur, Gleneagles Hospital Penang, Pantai Hospital Ayer Keroh, Pantai Hospital Kuala Lumpur, Pantai Hospital Penang and Prince Court Medical Centre.

"Public-private partnerships play an important role in bridging healthcare gaps, especially for life-threatening illnesses like cancer. By renewing our partnership, we are taking another step forward in our shared mission of making timely, high-quality care more accessible to those who need it most," said IHH Healthcare Chairman Tan Sri Dr Nik Norzrul Thani bin Nik Hassan Thani. 

Under the MOU, patients will be able to receive care at our facilities equipped with advanced technologies such as Gamma Knife and Linear Accelerator (LINAC). These allow for precision tumour targeting while preserving healthy tissue. The initiative also supports the goals outlined in Malaysia’s National Cancer Control Blueprint, particularly the need for earlier intervention and broader access to cancer services.

“Cancer care is not just about cutting-edge equipment. It is also about compassion and commitment. We know the financial burden can be overwhelming, especially in today’s environment. By renewing this MOU, we are reaffirming our role in supporting the public healthcare system and easing that burden where we can," said IHH Healthcare Group CEO Dr Prem Kumar Nair.

“This partnership began with a clear purpose: to close the gap in access to timely, quality cancer care. Treating 1,000 patients so far shows the real impact of that commitment. As we enter this next phase, we remain focused on working with the MOH to ensure more patients receive the care they need, when they need it,” said IHH Healthcare Malaysia CEO Jean-François Naa.

The renewed partnership strengthens our commitment to building a more sustainable healthcare ecosystem. By combining advanced clinical capabilities with our aspiration to Care. For Good., we are catalysing positive change and making quality healthcare more accessible to the communities we serve.

Related Stories

Fortis Healthcare Hosts 1st Annual Neuro-conclave Mumbai 2026

Fortis Healthcare marked the successful conclusion of the 1st Annual Neuro-conclave Mumbai 2026, held on 21 and 22 March, showcasing the strength and integration of its neuroscience team.

08 Jul 2025
Read More

IHH Malaysia Supports 10KM Category at Penang Bridge International Marathon

IHH Malaysia is the 10KM title sponsor for the upcoming Penang Bridge International Marathon 2026 (PBIM), encouraging individuals of all fitness levels to embrace a more active lifestyle.

08 Jul 2025
Read More

IHH Singapore Recognised for Contributions to SGSHARE Initiative

 

IHH Singapore was recognised by Community Chest Singapore at the SG60 Appreciation Ceremony on 7 March 2026 for our contributions to the SGSHARE initiative.

 

 

08 Jul 2025
Read More

Enhancing Patient Journeys at Pantai Hospital Melaka

Pantai Hospital Melaka has completed a series of facility enhancements aimed at creating smoother patient journeys and a more welcoming environment for patients and visitors.
08 Jul 2025
Read More

Restoring the Gift of Hearing at Gleneagles Hospital Kuala Lumpur

Clinical excellence across the IHH Healthcare network continues to transform lives in meaningful ways. At Gleneagles Hospital Kuala Lumpur, part of IHH Healthcare, a team of specialists recently achieved a significant milestone with the hospital’s first bilateral smart cochlear implant surgery.
08 Jul 2025
Read More

Gleneagles Hong Kong Partners with Emerging Viral Diagnostics and Mannings to Expand Community Healthcare

Gleneagles Hong Kong has joined forces with Emerging Viral Diagnostics (EVDL) and Mannings to create an innovative community healthcare ecosystem, combining advanced diagnostics, healthcare expertise, and accessible community channels.

08 Jul 2025
Read More
HOSPITALS
PRIMARY CARE
ANCILLARY SERVICES
  • Acibadem Labmed Logo
  • Agilus Diagnostics Logo
  • Parkway Laboratories
  • Parkway Radiology Logo
  • Parkway Rehab Logo
  • Premier Integrated Labs Logo
  • Premier Integrated Rehab Logo